Literature DB >> 7387532

Bilateral radical neck dissections.

W F McGuirt, B F McCabe.   

Abstract

Of 697 patients undergoing radical neck dissection for head and neck cancer, 91 (13%) had bilateral radical neck dissection. No operative deaths occurred. The complication rate was least for staged second neck dissections (17 patients). While overall surgical and medical complication rates for simultaneous bilateral neck dissections (11 patients) were greater than those after staged and delayed (53 patients) neck dissections, surgical complication rates alone for these three groups were comparable. The combined group of patients treated aggressively by simultaneous or staged second neck dissection had no greater complication rate than patients (ten) treated by second neck dissection when metastasis became clinically evident later. These findings and evidence that 55% of these patients were alive after five years or died of unrelated causes encourage us to support more aggressive surgical therapy in patients with manifest or likely occult bilateral metastases from a head and neck primary carcinoma.

Entities:  

Mesh:

Year:  1980        PMID: 7387532     DOI: 10.1001/archotol.1980.00790310051013

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  3 in total

1.  Bilateral resection and reconstruction of internal jugular vein for thyroid carcinoma.

Authors:  N Takeichi; H Ezaki; M Nishiki; K Dohi; H Ushio; M Takenaka; T Matsuyama
Journal:  Jpn J Surg       Date:  1984-11

2.  Treatment of cervical lymph node metastasis from an unknown primary tumor, with a review of the literature.

Authors:  H J van der Planken; R M Tiwari; A B Karim
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

Review 3.  Outcomes in squamous cell carcinoma with advanced neck disease.

Authors:  James A Keir; Olivia J H Whiteside; Stuart C Winter; Sushir Maitra; Rogan C Corbridge; Graham J Cox
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.